ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,000 shares of the company's stock in a transaction that occurred on Monday, July 21st. The shares were sold at an average price of $18.50, for a total transaction of $37,000.00. Following the sale, the chief executive officer directly owned 137,500 shares of the company's stock, valued at approximately $2,543,750. This represents a 1.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
ReposiTrak Trading Up 1.8%
TRAK stock traded up $0.32 during midday trading on Friday, reaching $18.39. 25,814 shares of the company's stock traded hands, compared to its average volume of 61,961. ReposiTrak Inc. has a 52-week low of $15.72 and a 52-week high of $25.01. The company has a market cap of $336.17 million, a PE ratio of 54.09 and a beta of 0.51. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. The stock's 50-day moving average is $20.21.
ReposiTrak Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Monday, June 30th will be issued a dividend of $0.0182 per share. The ex-dividend date is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a yield of 0.39%. ReposiTrak's dividend payout ratio is currently 20.59%.
Institutional Trading of ReposiTrak
A hedge fund recently raised its stake in ReposiTrak stock. Ellsworth Advisors LLC raised its holdings in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 31,289 shares of the company's stock after buying an additional 2,997 shares during the period. Ellsworth Advisors LLC owned about 0.17% of ReposiTrak worth $634,000 at the end of the most recent quarter. 27.35% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Read Our Latest Research Report on ReposiTrak
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Further Reading
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access